Wertpapierdatensatz · archiviertes Quartal
CRVS
Corvus Pharmaceuticals, Inc. · Healthcare · Biotechnology
56Erfasste Halter
+2Δ Inhaber
25.04MGehaltene Aktien
$192.77MGemeldeter Wert
+2Neue Positionen
−0Ausstiege
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +3.7% ·
Aktienfluss +14.5% ·
neue Nettopositionen +3.6%
· Formel
Breite Akkumulation: steigende Aktienanzahl bei mehr Inhabern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q4 2025
Beteiligung im Zeitverlauf
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q2 2026 | 68 | +6 | 34.72M | $518.70M | +11 | −5 |
| Q1 2026 | 64 | +8 | 30.80M | $450.00M | +15 | −7 |
| Q4 2025 | 56 | +2 | 25.04M | $192.77M | +2 | n/a |
| Q3 2025 | 14 | 0 | 18.71M | $137.91M | +2 | −2 |
| Q2 2025 | 11 | -1 | 17.31M | $69.23M | +1 | −2 |
| Q1 2025 | 9 | +2 | 6.14M | $19.53M | +2 | n/a |
| Q4 2024 | 7 | -1 | 4.46M | $23.85M | n/a | −1 |
| Q3 2024 | 7 | 0 | 7.32M | $38.63M | n/a | n/a |
| Q2 2024 | 7 | n/a | 7.37M | $13.41M | n/a | n/a |
Wer es hält · Q4 2025
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 3.87M | +11.6% | $29.83M | 0.0% | ▲ Add | 3 | SEC ↗ ×3 |
| 2 | Morgan Stanley ✦ | 3.57M | +478.1% | $27.47M | 0.0% | ▲ Add | 2 | SEC ↗ ×6 |
| 3 | State Street Global Advisors ✦ (passiv) | 2.79M | +177.1% | $21.47M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 1.47M | +1.1% | $11.35M | 0.0% | ▲ Add | 7 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 688.77K | Neu | $5.30M | 0.0% | New | 1 | SEC ↗ |
| 6 | Goldman Sachs Group ✦ | 553.33K | +24.2% | $4.26M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | Northern Trust Corp | 429.77K | n/a | $3.31M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 8 | Barclays Plc | 394.77K | n/a | $3.04M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | Wellington Management ✦ | 314.68K | +74.7% | $2.42M | 0.0% | ▲ Add | 4 | SEC ↗ ×3 |
| 10 | Bank Of America Corp /De/ | 236.50K | n/a | $1.82M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 11 | Marshall Wace ✦ | 216.25K | Neu | $1.67M | 0.0% | New | 1 | SEC ↗ ×2 |
| 12 | Citadel Advisors ✦ | 208.18K | +386.8% | $1.60M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Charles Schwab Investment… | 171.17K | n/a | $1.32M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 143.60K | -29.4% | $1.11M | 0.0% | ▼ Trim | 7 | SEC ↗ |
| 15 | Bank of New York Mellon Corp | 131.63K | n/a | $1.01M | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 16 | Raymond James Financial Inc | 121.16K | n/a | $932,909 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 17 | Hsbc Holdings Plc | 118.54K | n/a | $902,074 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 18 | Rhumbline Advisers | 70.73K | n/a | $544,591 | 0.0% | n/c | 1 | SEC ↗ |
| 19 | D. E. Shaw & Co. ✦ | 64.92K | +153.8% | $499,846 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 20 | Wells Fargo & Company/Mn | 62.62K | n/a | $482,198 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 21 | Deutsche Bank Ag\ | 56.04K | n/a | $431,500 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 22 | Invesco Ltd. | 43.58K | n/a | $335,589 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 23 | T. Rowe Price ✦ | 34.10K | +5.2% | $263,000 | 0.0% | ▲ Add | 3 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 30.66K | -52.5% | $236,043 | 0.0% | ▼ Trim | 2 | SEC ↗ ×4 |
| 25 | Voya Investment Management Llc | 27.66K | n/a | $212,990 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 26 | Group One Trading Llc | 26.67K | n/a | $205,336 | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Balyasny Asset Management L.P. | 25.03K | n/a | $192,739 | 0.0% | n/c | 1 | SEC ↗ |
| 28 | New York State Common Retirement… | 18.80K | n/a | $144,760 | 0.0% | n/c | 1 | SEC ↗ |
| 29 | Manufacturers Life Insurance… | 17.50K | n/a | $134,727 | 0.0% | n/c | 1 | SEC ↗ |
| 30 | Alliancebernstein L.P. | 17.12K | n/a | $131,824 | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Citigroup Inc | 14.86K | n/a | $114,407 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 32 | ProShare Advisors LLC | 13.76K | n/a | $105,983 | 0.0% | n/c | 1 | SEC ↗ |
| 33 | Bnp Paribas Financial Markets | 6.57K | n/a | $50,558 | 0.0% | n/c | 1 | SEC ↗ |
| 34 | Legal & General Group Plc | 5.79K | n/a | $44,560 | 0.0% | n/c | 1 | SEC ↗ |
| 35 | California State Teachers… | 3.52K | n/a | $27,135 | 0.0% | n/c | 1 | SEC ↗ |
| 36 | Fidelity (FMR) ✦ | 2.29K | +55.6% | $17,643 | 0.0% | ▲ Add | 3 | SEC ↗ ×2 |
| 37 | Royal Bank Of Canada | 1.62K | n/a | $12,000 | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 38 | UBS AM, a distinct business unit of… | 725 | n/a | $5,583 | 0.0% | n/c | 1 | SEC ↗ |
| 39 | Pnc Financial Services Group, Inc. | 137 | n/a | $1,055 | 0.0% | n/c | 1 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Millennium Management | $5.30M | 0.0% |
| Marshall Wace | $1.67M | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 163 Inhaber, 69.83M Anteile, $976.09M gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Häufig gemeinsam gehalten
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.
Herkunft: Beteiligung aus geparsten 13F-Common-Stock-Positionen (verfolgte Grundgesamtheit, vergleichbare Sets für Veränderungen); Insider-Zeilen aus Formularen 3/4/5; Beteiligungen aus Schedules 13D/13G; jede Einreichung verlinkt auf das Original auf SEC EDGAR.
Berichtszeitraum: Q4 2025 ·
Methodik ·
Über die API abrufen